This website uses cookies

To give you the best possible experience, this site uses cookies. Continuing to use means you agree to our use of cookies. For more information about the cookies we use, please see our Cookie Policy.

Accept and Close

Board of Directors

Dr. William E. Reichman
Dr. William E. Reichman
Dr. William Reichman is President and Chief Executive Officer of Baycrest, one of the world's premier academic health sciences centres focused on aging and brain function. Dr. Reichman, an internationally-known expert in geriatric mental health and dementia, is also Professor of Psychiatry on the Faculty of Medicine at the University of Toronto and a Director of Cogniciti Inc., Baycrest's investment (with MaRS Discovery District) into the brain health commercialization space. He is a noted authority on the delivery of mental health and dementia services in nursing home settings.

Dr. Reichman received a B.S. from Trinity College in 1979 and an M.D. degree from the State University of New York at Buffalo, School of Medicine in 1984. He pursued residency training in general adult psychiatry at the University of California at Los Angeles (UCLA) Neuropsychiatric Institute and completed fellowship training in neurobehavior at the UCLA Reed Neurological Research Institute.

Dr. Reichman is a former President of the American Association for Geriatric Psychiatry and the Geriatric Mental Health Foundation and served as a consultant to the Civil Rights Division of the United States Department of Justice on dementia and mental health-care delivery within nursing homes. He previously served as the Senior Health columnist for the Star Ledger, New Jersey's highest circulation newspaper and has been interviewed and quoted by most of the major media outlets in the United States and Canada. Among honors received, Dr. Reichman is named among the Best Doctors in America and Canada and previously has been recognized by the New Jersey Society on Aging as Gerontologist of the Year. He is a recipient of a Bronze Telly award for an educational documentary film entitled, Reflections of Memory Lost: Understanding Alzheimer's disease.

Dr. Ilse Treurnicht
Dr. Ilse Treurnicht
Ilse Treurnicht was the former CEO of MaRS Discovery District, a leading innovation centre located in Toronto. She oversaw both the development and operations of the MaRS Centre and its broad suite of entrepreneurship and innovation programs. Ilse is also a Director of Cogniciti Inc., MaRS Discovery District's investment (together with Baycrest) into the brain health commercialization space.

MaRS offers advisory services, market intelligence and entrepreneurship education to emerging companies across Ontario in life sciences and healthcare; IT, communications and entertainment (ICE); cleantech; and social innovation.

Ilse joined MaRS in early 2005 from her role as President & CEO of Primaxis Technology Ventures, a startup-stage venture capital fund focused on the advanced technologies sector. Prior to Primaxis, Ilse was an entrepreneur with senior management roles in a number of emerging technology companies.

Ilse holds a DPhil in chemistry from Oxford University, which she attended as a Rhodes scholar.

Garry Foster
Garry Foster
Garry Foster is Chair of Cogniciti's Board of Directors, Past CEO of the Baycrest Foundation, and Past Chair of Baycrest.

In June 2013, Garry retired from Deloitte after 38 years where his most recent appointment was as Vice Chairman Deloitte Canada. While at Deloitte, Garry advised some of Canada's largest and most prestigious companies on governance, merger, acquisition and financing activities. From 1998 to 2006 Garry led the firm's Canadian Technology, Media and Telecommunications (TMT) practice and was a member of the global TMT executive committee. He was a member of the Deloitte Canada Board of Directors, Chair of the Compensation Committee, and Past Chair of the Governance and Succession Planning Committees. He was a member of the Deloitte U.S. Board of Directors and served on numerous outside Boards during his tenure at Deloitte.

Garry is a graduate of the Schulich School of Business, York University, receiving his BBA in 1974 and his MBA in 1975. He also received his CA designation in 1976, his FCA designation in 1991 and his ICD.D in 2008 from the University of Toronto.

Cogniciti - Brain Health Powered by Science